pre-miRNA Information
pre-miRNA hsa-mir-3940   
Genomic Coordinates chr19: 6416410 - 6416511
Description Homo sapiens miR-3940 stem-loop
Comment None
RNA Secondary Structure
Associated Diseases

Mature miRNA Information
Mature miRNA hsa-miR-3940-3p
Sequence 57| CAGCCCGGAUCCCAGCCCACUU |78
Evidence Experimental
Experiments Illumina
DRVs in miRNA
Mutant ID Mutant Position Mutant Source
COSN7451488 7 COSMIC
COSN8606686 12 COSMIC
COSN26556646 17 COSMIC
COSN32052209 22 COSMIC
SNPs in miRNA
Mutant ID Mutant Position Mutant Source
rs1038465553 2 dbSNP
rs779012242 3 dbSNP
rs753266822 4 dbSNP
rs766893050 6 dbSNP
rs1436139782 7 dbSNP
rs1402099476 8 dbSNP
rs1302859978 13 dbSNP
rs759153046 16 dbSNP
rs559739712 19 dbSNP
rs187508006 20 dbSNP
Putative Targets

miRNA Expression profile
Human miRNA Tissue Atlas
miRNAs in Extracellular Vesicles
Circulating MicroRNA Expression Profiling
Gene Information
Gene Symbol PPP1R11   
Synonyms CFAP255, HCG-V, HCGV, IPP3, TCTE5, TCTEX5
Description protein phosphatase 1 regulatory inhibitor subunit 11
Transcript NM_021959   
Expression
Putative miRNA Targets on PPP1R11
3'UTR of PPP1R11
(miRNA target sites are highlighted)
>PPP1R11|NM_021959|3'UTR
   1 ATCCCTCTCTCCTCCAGCATTCCTGTGTCTGTCTGGCCCTAAATGTATCCATGTGGCTACTTCTCCAGCCCCCTCCTTCC
  81 CTCTCTTCTGCCTGATAGAGGGAAGAGGAAGAGGAGGACGAACAGAGATCCTGAAATTCTGACTTGCTGCTATTCCAGAA
 161 CCCAGCCTCCTGGGTTTCCCCAGTCCTCATTTTTCCTCCCAATACCCACCCTTCTCTCTCGAGGGATCTAGGCACCTTGG
 241 TCCCAGTGTCTTCCTTTTGTTCTCACTGCCAAACTGCCTGTCCTGGGATCTAGTTATCTTGGCCCTGCACTCTCAACATG
 321 AGTAGCGAACACTTAAATTGGGTTTTCAACAGTCCCAGCTTTCACTGCCAGGGTCCCAGTCAGATTCCAGGAATTTGCGC
 401 CCTAACTTTGCTTGCTAATCCTGGTTTAGAGCTATCCCACTAAAATATTTAATCCTAATTCTTAGTCCTTGCCTGTGAGA
 481 TATGAGGTCTTACAGGAGACCTCAGAGCTCCCAGCCCTTCTCCTCCTGCTAACCCTTCTCACACCCTCAAGAGGAGTTAG
 561 AAAAGAGGTCCTTGTCATTCTCACCTCTTATGGAAAATGGAATAAGAAATAATCATATCCTTTCTTCCCACCCTTCTCCT
 641 GTTATTTAGGATTTCTGACAAAGCTGGCTTGAGATTGGTCACTTAGAGCCGACTGTCTCCTCTGCCTTTTGTTTTTCAGC
 721 TTCAGAGACAGATCCAATATAGTCCCAGGGACCTGGGTCTCTGGGAGAGGAAGGAAGAGGGAGGGAGCAAAGAGATTGGG
 801 GTATGTCCCCTGTAGTACACTCTTACCTCTTACTTCCTAGACTTTGATTTCTCCGGCAGCCCAGATGTTCAGTTCTCTTG
 881 GCCCCTCTCTACCCCTTACTGGGATCCGGTTTTCATTTTCCGGTCCTTTTGCCATACACAGTTACAGAGATCAGTCAAAT
 961 CCATACCACCACTGAGATCTCATTTATTGCCACAGATGCACAAAATAAATAACCCAAAATCACAAAA
Target sites Provided by authors   Predicted by miRanda    DRVs    SNPs    DRVs & SNPs
miRNA-target interactions
(Predicted by miRanda)
ID Duplex structure Position Score MFE
1
miRNA  3' uucacccGACCCUAGGCCCGAc 5'
                 ||||||||||| :| 
Target 5' ccccttaCTGGGATCCGGTTTt 3'
892 - 913 127.00 -22.90
2
miRNA  3' uucacccGACCCUAGGCCC-GAc 5'
                 | |||| |:||| || 
Target 5' atagtccCAGGGACCTGGGTCTc 3'
739 - 761 111.00 -15.00
3
miRNA  3' uucacccgacccuaGGCCCGAc 5'
                        |:|||:| 
Target 5' cagaacccagcctcCTGGGTTt 3'
156 - 177 108.00 -10.90
DRVs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
COSN30159376 4 COSMIC
COSN30478804 4 COSMIC
COSN30486764 5 COSMIC
COSN31599999 65 COSMIC
COSN30172918 66 COSMIC
COSN30495389 94 COSMIC
COSN30157304 99 COSMIC
COSN31548225 130 COSMIC
COSN31562048 151 COSMIC
COSN30108732 221 COSMIC
COSN28695733 271 COSMIC
COSN21017766 328 COSMIC
COSN31962605 364 COSMIC
COSN31513265 373 COSMIC
COSN27055675 594 COSMIC
COSN28693749 975 COSMIC
rs6539 908 GWAS
SNPs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
rs1199116754 3 dbSNP
rs1490633555 8 dbSNP
rs1268474344 14 dbSNP
rs1031339343 15 dbSNP
rs1179183273 23 dbSNP
rs767896119 27 dbSNP
rs753664615 32 dbSNP
rs1162865778 40 dbSNP
rs540656192 41 dbSNP
rs370011121 47 dbSNP
rs1353595762 54 dbSNP
rs1271714373 66 dbSNP
rs1219112104 67 dbSNP
rs1439536233 69 dbSNP
rs1319884051 70 dbSNP
rs185477475 71 dbSNP
rs914479779 74 dbSNP
rs1295439918 82 dbSNP
rs532503020 102 dbSNP
rs953906616 115 dbSNP
rs371455524 120 dbSNP
rs910660063 121 dbSNP
rs1467288753 130 dbSNP
rs375944037 135 dbSNP
rs1344155356 144 dbSNP
rs1480933236 163 dbSNP
rs763335445 168 dbSNP
rs569339833 173 dbSNP
rs1192528763 176 dbSNP
rs1040820262 195 dbSNP
rs570172216 203 dbSNP
rs531558835 221 dbSNP
rs919282238 221 dbSNP
rs369235796 222 dbSNP
rs768570003 225 dbSNP
rs1228895343 226 dbSNP
rs929262983 231 dbSNP
rs1049369328 241 dbSNP
rs1437502100 245 dbSNP
rs1221913204 247 dbSNP
rs1372838993 255 dbSNP
rs9261288 271 dbSNP
rs1449067175 280 dbSNP
rs1239343197 286 dbSNP
rs1013124695 297 dbSNP
rs1336568250 316 dbSNP
rs1470605405 316 dbSNP
rs568380079 318 dbSNP
rs1361210469 323 dbSNP
rs533838544 327 dbSNP
rs189714956 328 dbSNP
rs1406784985 342 dbSNP
rs1178880829 348 dbSNP
rs528568418 350 dbSNP
rs1044578138 374 dbSNP
rs1168899379 378 dbSNP
rs1419228980 393 dbSNP
rs907324509 395 dbSNP
rs1213384421 398 dbSNP
rs751706395 399 dbSNP
rs180960420 400 dbSNP
rs955732905 410 dbSNP
rs1380621038 412 dbSNP
rs1011176502 432 dbSNP
rs1396724754 437 dbSNP
rs1381931131 458 dbSNP
rs1287699558 484 dbSNP
rs1346163340 486 dbSNP
rs1335777993 499 dbSNP
rs1359311713 509 dbSNP
rs1158837106 520 dbSNP
rs9261289 534 dbSNP
rs1383055091 539 dbSNP
rs1334061700 541 dbSNP
rs953958995 544 dbSNP
rs1423959620 545 dbSNP
rs1258170931 550 dbSNP
rs1184718190 552 dbSNP
rs373487322 557 dbSNP
rs11543131 559 dbSNP
rs781601379 575 dbSNP
rs2240067 577 dbSNP
rs552227100 592 dbSNP
rs8347 604 dbSNP
rs1245606319 620 dbSNP
rs1323642546 620 dbSNP
rs1293975507 625 dbSNP
rs528454228 627 dbSNP
rs1341467534 633 dbSNP
rs115882910 635 dbSNP
rs554847473 637 dbSNP
rs115855070 644 dbSNP
rs1292648187 658 dbSNP
rs1049089458 666 dbSNP
rs1369697171 667 dbSNP
rs909178519 668 dbSNP
rs1424305557 672 dbSNP
rs1195533955 673 dbSNP
rs1241327016 682 dbSNP
rs1466678748 686 dbSNP
rs948951822 691 dbSNP
rs374353348 692 dbSNP
rs1210666750 695 dbSNP
rs1489483170 730 dbSNP
rs1249711986 731 dbSNP
rs560727348 738 dbSNP
rs377737924 743 dbSNP
rs1319170199 748 dbSNP
rs1280719328 750 dbSNP
rs1474635154 751 dbSNP
rs1222049655 754 dbSNP
rs1345284131 764 dbSNP
rs1300090186 770 dbSNP
rs1387029031 780 dbSNP
rs1392201313 781 dbSNP
rs771984764 797 dbSNP
rs116237627 798 dbSNP
rs1464686547 802 dbSNP
rs1052894912 806 dbSNP
rs1429584902 818 dbSNP
rs1468928645 822 dbSNP
rs1051133 826 dbSNP
rs1011233692 827 dbSNP
rs1021256568 837 dbSNP
rs1435104552 838 dbSNP
rs953676517 855 dbSNP
rs1195295144 856 dbSNP
rs1006829034 883 dbSNP
rs186201160 886 dbSNP
rs1202337357 895 dbSNP
rs1323232550 897 dbSNP
rs1256978845 900 dbSNP
rs6539 908 dbSNP
rs768114414 909 dbSNP
rs1304504763 917 dbSNP
rs1438357372 921 dbSNP
rs1445388150 922 dbSNP
rs776368761 935 dbSNP
rs554336785 938 dbSNP
rs770230037 940 dbSNP
rs1468187948 948 dbSNP
rs1346435639 950 dbSNP
rs950786314 951 dbSNP
rs1467451160 961 dbSNP
rs551000157 962 dbSNP
rs144268715 970 dbSNP
rs12526 975 dbSNP
rs1205723308 983 dbSNP
rs1351943516 983 dbSNP
rs948670342 987 dbSNP
rs1240143468 1017 dbSNP
rs1182236160 1019 dbSNP
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions TZM-bl
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL ...

- Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio.

Article - Whisnant AW; Bogerd HP; Flores O; Ho P; et al.
- mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
CLIP-seq Support 1 for dataset GSM1462574
Method / RBP PAR-CLIP / AGO2
Cell line / Condition TZM-bl / TZM-bl ami BaL
Location of target site ENST00000376773.1 | 3UTR | UCUCUUGGCCCCUCUCUACCCCUUACUG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 23592263 / GSE59944
CLIP-seq Viewer Link
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
KIRC 0.559 0.01 0.591 0 19 Click to see details
LIHC 0.314 0.03 0.210 0.1 38 Click to see details
THCA -0.163 0.15 -0.146 0.18 43 Click to see details
KICH 0.329 0.15 0.483 0.06 12 Click to see details
UCEC -0.234 0.24 -0.227 0.25 11 Click to see details
HNSC 0.164 0.26 0.218 0.2 17 Click to see details
STAD -0.209 0.29 -0.033 0.47 9 Click to see details
ESCA -0.3 0.35 -0.400 0.3 4 Click to see details
LUSC 0.071 0.37 -0.045 0.41 26 Click to see details
KIRP 0.106 0.37 0.082 0.39 13 Click to see details
LUAD 0.141 0.37 0.143 0.37 8 Click to see details
CHOL 0.175 0.41 0.400 0.3 4 Click to see details
BRCA 0.037 0.42 -0.009 0.48 33 Click to see details
PRAD 0.106 0.42 0.029 0.48 6 Click to see details
BLCA -0.08 0.43 0.000 0.5 8 Click to see details
BLCA -0.08 0.43 0.000 0.5 8 Click to see details
BLCA -0.08 0.43 0.000 0.5 8 Click to see details
BLCA -0.08 0.43 0.000 0.5 8 Click to see details
BLCA -0.08 0.43 0.000 0.5 8 Click to see details
42 hsa-miR-3940-3p Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT118010 BLOC1S3 biogenesis of lysosomal organelles complex 1 subunit 3 2 6
MIRT268170 POU2F1 POU class 2 homeobox 1 2 2
MIRT289461 BIRC5 baculoviral IAP repeat containing 5 2 4
MIRT409766 HRH2 histamine receptor H2 2 2
MIRT452070 ZNF585B zinc finger protein 585B 2 8
MIRT458519 GSG2 histone H3 associated protein kinase 2 6
MIRT458657 SGPP2 sphingosine-1-phosphate phosphatase 2 2 2
MIRT465898 TMEM41B transmembrane protein 41B 2 2
MIRT469877 PURB purine rich element binding protein B 2 4
MIRT470462 PPP1R11 protein phosphatase 1 regulatory inhibitor subunit 11 2 2
MIRT481439 ASB6 ankyrin repeat and SOCS box containing 6 2 2
MIRT482643 RPL18A ribosomal protein L18a 2 2
MIRT486034 CYTH1 cytohesin 1 2 2
MIRT486423 RXRA retinoid X receptor alpha 2 2
MIRT490254 MFI2 melanotransferrin 2 2
MIRT491213 MLLT1 MLLT1, super elongation complex subunit 2 4
MIRT492849 NRGN neurogranin 2 2
MIRT492995 NAV1 neuron navigator 1 2 2
MIRT493423 KDM6B lysine demethylase 6B 2 2
MIRT495331 MON1B MON1 homolog B, secretory trafficking associated 2 2
MIRT496865 C21orf2 chromosome 21 open reading frame 2 2 2
MIRT498435 EHD4 EH domain containing 4 2 2
MIRT514977 CCBE1 collagen and calcium binding EGF domains 1 2 2
MIRT525668 KXD1 KxDL motif containing 1 2 2
MIRT564349 AKR1B10 aldo-keto reductase family 1 member B10 2 2
MIRT565241 TRAF6 TNF receptor associated factor 6 2 2
MIRT573209 C12orf49 chromosome 12 open reading frame 49 2 2
MIRT635215 ZNF286A zinc finger protein 286A 2 4
MIRT638282 SH2B3 SH2B adaptor protein 3 2 2
MIRT650230 SIGLEC9 sialic acid binding Ig like lectin 9 2 2
MIRT665256 ZNF286B zinc finger protein 286B 2 2
MIRT665833 TIMELESS timeless circadian clock 2 2
MIRT666891 POLA2 DNA polymerase alpha 2, accessory subunit 2 2
MIRT667161 NRXN3 neurexin 3 2 2
MIRT679853 GPR75 G protein-coupled receptor 75 2 2
MIRT680747 CA5B carbonic anhydrase 5B 2 2
MIRT682071 QPCTL glutaminyl-peptide cyclotransferase like 2 2
MIRT695801 SCUBE3 signal peptide, CUB domain and EGF like domain containing 3 2 2
MIRT705465 ATG9A autophagy related 9A 2 2
MIRT714270 LTBP2 latent transforming growth factor beta binding protein 2 2 2
MIRT716392 NPAS1 neuronal PAS domain protein 1 2 2
MIRT718443 RAB11B RAB11B, member RAS oncogene family 2 2
miRNA-Drug Associations
miRNA Small Melocule FDA CID Detection Method Condition PMID Year Expression Pattern of miRNA
miR-3940-3p Hydroxycamptothecin (HCPT) NULL 97226 Microarray human Tenon's fibroblasts (HTFs) 24681041 2014 up-regulated
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-mir-3940 Dabrafenib 44462760 NSC764134 approved resistant cell line (A375)
hsa-miR-3940-3p Gemcitabine 60750 NSC613327 approved resistant High Pancreatic Cancer cell line (PANC-1)
hsa-miR-3940-3p Fluorouracil 3385 NSC19893 approved resistant High Pancreatic Cancer cell line (PANC-1)
hsa-miR-3940-3p Gefitinib 123631 NSC715055 approved sensitive cell line (HCC827)
hsa-miR-3940-3p Osimertinib 71496458 NSC779217 approved sensitive cell line (HCC827)
hsa-miR-3940-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (CP20)
hsa-miR-3940-3p Fluorouracil 3385 NSC19893 approved resistant cell line (HCT15)
hsa-miR-3940-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (A2780)
hsa-miR-3940-3p Platinum 23939 sensitive tissue (non-small cell lung cancer)
hsa-miR-3940-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (A549)
hsa-miR-3940-3p Gemcitabine 60750 NSC613327 approved sensitive cell line (PANC-1) (100 ng/ml)
hsa-miR-3940-3p Gemcitabine 60750 NSC613327 approved resistant cell line (PANC-1) (1500 ng/ml)
hsa-miR-3940-3p Gemcitabine 60750 NSC613327 approved resistant cell line (Panc1-GR4)

Error report submission